Lv52
1460 积分 2023-12-22 加入
Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial
1小时前
已完结
Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial
1小时前
已完结
Anlotinib versus Placebo as Adjuvant Therapy for Localized High-Grade Soft-Tissue Sarcomas: A Phase II, Double-Blinded, Randomized Controlled Trial
1天前
已完结
国家卫生健康委员会中国结直肠癌诊疗规范(2023版)
16天前
已完结
Global Burden of Thrombosis: Epidemiologic Aspects
1个月前
已完结
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
1个月前
已完结
Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer
1个月前
已完结
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial
1个月前
已完结
Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus
1个月前
已完结
A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma
1个月前
已完结
额颞叶痴呆的诊断研究进展
1年前
已采纳
皖公网安备34019202002308
